Trade HCWB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
HCW Biologics Inc. (HCWB) is trading at US$1.87, down 4.10% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$4M. Over the past 52 weeks, HCWB has traded between US$1.50 and US$29.28. On Syfe you can trade HCWB with $0 commission and add it to your watchlist.
| Previous close | US$1.95 |
|---|---|
| Market cap | US$4M |
| 52-week range | US$1.50 – US$29.28 |
| Volume | 87.47K |
| Exchange | US |
Add to Watchlist
Set Price Alert
HCW Biologics Inc.
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
Year: 2021
HCW Biologics Prices $1.6 Million Private Placement Offering
Jul 29, 3:12 PM · MT Newswires
HCW Biologics to Implement 1-for-6 Reverse Stock Split
Jun 30, 3:55 PM · MT Newswires
HCW Biologics Board Approves 1-for-6 Reverse Stock Split
Jun 26, 1:21 PM · MT Newswires
HCW Biologics Registers Resale of Up to 5.7 Million Shares
Jun 8, 3:19 PM · MT Newswires
HCW Biologics Inc. (HCWB) stock is trading at US$1.87, -4.10% from the previous close of US$1.95.
The market cap for HCW Biologics Inc. (HCWB) stock is approximately US$4M.
The 52-week high for HCW Biologics Inc. (HCWB) stock is US$29.28.
The 52-week low for HCW Biologics Inc. (HCWB) stock is US$1.50.
HCW Biologics Inc. (HCWB) does not currently pay a dividend.
Stay on top of HCWB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
